Most edge AI dev boards make you evaluate the chip while it's attached to a computer. BrainBoard1500 doesn't.
AKD1500 in the Arduino Nicla form factor, direct to the sensor, with a current monitor so you can see exactly what your model costs in power. Built with @neuromorphyx.
🔗 https://t.co/zcVJaGfofm
The spectrum is crowded. Contested. And your classifier needs to work where the noise is worst — on-device, sub-millisecond, no cloud.
🔗 https://t.co/8Cqeeczly4
#RFClassification#EdgeAI
🚨 Institutional exposure to $BRN $BRCHF is broader than many investors realize.
13 ETFs now hold BrainChip, including:
🧠 $WISE – Themes Generative Artificial Intelligence ETF
• 2.72% portfolio weight
• 8.2M+ BrainChip shares
• ~US$907K invested
• One of the ETF’s meaningful AI positions.
💻 $ATEC – BetaShares Australian Technology ETF
• ~US$1.16M invested
• Technology-focused Australian ETF.
🌍 Global index exposure through:
• $VSS (Vanguard FTSE All-World ex-US Small-Cap ETF) – ~US$977K
• $SCHC (Schwab International Small-Cap Equity ETF) – ~US$476K
• $GWX (SPDR S&P International Small Cap ETF) – ~US$95K
• Plus ZINN, VPL, V3PA, V3PL, VA, ZAUT and other ETFs.
While many of the larger index ETFs hold BrainChip passively, WISE stands out by assigning a 2.72% portfolio weight, reflecting a deliberate AI allocation.
As BrainChip grows, broader ETF inclusion and larger index weightings could increase institutional ownership over time.
#BrainChip Announces Commercial Availability and Production Shipments of #AKD1500#Neuromorphic Processors.
Production quantities are currently shipping to customers as the chip undergoes comprehensive industrial and military-grade qualification.
https://t.co/Mzrum3kiLV
This article is quite significant for BrainChip investors because it moves the discussion beyond “Akida as a chip” and toward “Akida as part of an enterprise-scale AI architecture.”
$BRCHF $BCHPY $BRN.ASX
📢The Phase 1/2a HEADLINE Trial of ABS-201, an AI-designed antibody for Androgenetic Alopecia (commonly known as female/male pattern hair loss) is now enrolling participants.
Independent validation of BrainChip’s Akida technology 🚀
A new Scientific Reports paper achieved 94.44% accuracy after converting AkidaNet to a Spiking Neural Network (SNN) using BrainChip’s CNN2SNN toolchain for cotton weed classification.
$BRCHF $BCHPY $BRN
Three shifts are defining the next generation of #financialinfrastructure: settlement moving from batch to continuous, siloed systems becoming interoperable, and manual processes becoming programmable.
2026 is when it stops being a roadmap and starts being operational: https://t.co/126YaEbRLa
#Programmability #Settlement #Interoperability
$QNT
Rewards
Rewards on Overledger are evolving in step with the upcoming Fusion Rollup Mainnet and Staking program. Early activity you accumulate here — opting in to campaigns, completing tasks, and claiming QNT — feeds directly into the Fusion ecosystem you’ll be staking into at mainnet launch.
Today’s campaigns are the on-ramp: every QNT you earn now puts you in position to stake on Fusion Rollup Mainnet from day one, with no separate setup required when the program goes live.
When the Fusion Rollup Mainnet ships, the same Overledger account you use here becomes your staking identity. Balances earned through campaigns can be staked alongside QNT you already hold, giving you a head start on rollup-level rewards (sequencer participation, validator delegation, and ecosystem incentives) the moment staking opens. Opt in early, claim as you go, and you’ll arrive at mainnet with QNT ready to put to work — no migration, no waitlist, no missed epochs.
Big news! We are welcoming @MulticoreWare, @PProduct2006, and https://t.co/A7Iff5zgZX as strategic software partners to develop and optimize advanced ML models for the AKD1500.
More partners. More models. More power at the edge 🔥
🔗 https://t.co/XUtAzbNEvt